Avanos Medical, Inc. (AVNS): PT Cut To $67 But Thesis Confirmed Intact By CEO/Investor Call At KeyBanc
Tweet Send to a Friend
KeyBanc analyst, Matthew Mishan, reiterated his Sector Weight rating on shares of Avanos Medical (NYSE: AVNS) and trimmed his PT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


